What happens in the neurology appointment
A standard neurology outpatient appointment for a patient with established MS focuses, appropriately, on disease activity. MRI findings are reviewed. Relapse history is taken. The clinical examination assesses neurological function. Disease-modifying therapy is managed — the selection, monitoring, and switching of immunomodulatory drugs that remain the central pillar of conventional MS treatment. This is important and often excellent clinical work. But it covers perhaps 30 percent of what materially affects the quality of life and long-term trajectory of a person living with MS.
The other 70 percent — fatigue management, cognitive function, gut health, nutritional status, hormonal balance, sleep quality, exercise physiology, psychological resilience, and the evidence-based lifestyle interventions with documented effects on MS outcomes — is largely managed elsewhere, or not managed at all. Partly because the neurology appointment is not the right vehicle for it. Partly because the practitioners who could address it are not in communication with the neurologist. Partly because the patient has not been signposted to them, or cannot access them, or is simply too fatigued to pursue them all independently.
"The disease-modifying therapy manages the immunological attack on myelin. It does not manage the fatigue that prevents a person from working, the cognitive fog that prevents them from reading, or the gut dysfunction that impairs the absorption of the very nutrients that support neurological function."
The vitamin D story
The relationship between vitamin D and MS is among the most robustly documented in immunological research. Population studies consistently show that people who grow up at higher latitudes — with less sun exposure and lower endogenous vitamin D production — have significantly higher rates of MS. Serum vitamin D levels at the time of a first demyelinating event are inversely correlated with subsequent disease activity. High-dose vitamin D supplementation studies have shown significant reductions in relapse rate and in markers of inflammatory activity in the CNS in some, though not all, clinical contexts.
Despite this evidence, vitamin D testing and supplementation is not standard practice in MS neurology clinics. It may be recommended but is not systematically monitored. The dose that population data suggests is protective — typically achieving serum 25-OH-D levels of 100-150 nmol/L — is higher than the doses that are routinely suggested and requires individual titration and monitoring. This falls between specialties: the neurologist does not typically manage nutritional supplementation, and the GP may not feel positioned to prescribe outside standard guidance.
The Overcoming MS evidence
The gut–MS connection
The gut microbiome in MS patients is measurably different from that of healthy controls — with characteristic changes in specific bacterial populations that have immunomodulatory roles. The gut-immune-brain axis appears to be a significant pathway in MS pathology. Intestinal permeability may contribute to the chronic low-grade systemic inflammation that precedes and accompanies CNS inflammation. Dietary interventions — particularly high-fibre diets that support microbiome diversity, and elimination of foods that increase intestinal permeability — have shown promise in early studies for improving quality of life and potentially influencing disease markers in MS.
Managing the full picture of MS
Disease-modifying therapy
The neurologist's domain — and critically important for reducing relapse rates and slowing disability progression. The foundation, not the ceiling, of MS management.
Fatigue management
MS-related fatigue is neurological, inflammatory, mitochondrial, and psychological in origin. A thorough approach requires assessment across all four — not simply an energy management plan.
Nutritional optimisation
Vitamin D, omega-3 index, B12, magnesium, and antioxidant status are all relevant to neurological function and inflammatory activity in MS and require systematic assessment and monitoring.
Gut health
Microbiome diversity and intestinal permeability assessment, with targeted dietary and supplement interventions, addressing the gut-immune-brain pathway that is increasingly understood to contribute to MS activity.
Exercise physiology
Regular aerobic exercise has some of the strongest evidence of any non-pharmacological intervention in MS — for fatigue, cognition, mood, and potentially disease course. Exercise prescription requires coordination with physiotherapy and knowledge of the patient's current capacity.
Psychological and cognitive support
Depression is two to three times more prevalent in MS than in the general population. Cognitive rehabilitation is documented to improve function in MS-related cognitive impairment. Both require dedicated clinical support that neurology appointments rarely provide.
Holding the full clinical picture of a person living with MS — across neurology, nutrition, gut health, physiotherapy, psychology, and lifestyle medicine — is not a luxury. It is what genuinely excellent MS care requires. Syva coordinates exactly this: ensuring that every practitioner involved in an MS patient's care is working from the same information, that the evidence-based adjuncts to neurological treatment are actively pursued, and that the patient is not carrying the weight of integrating it all themselves.